This prospective multicentre observational study investigated the risk of non-cardiac surgery in patients with moderate or severe aortic stenosis (AS). Patients with AS undergoing non-cardiac surgery in five New Zealand hospitals between August 2011 and September 2015 were studied. Preoperative variables were analysed for a significant association with postoperative major adverse cardiac events (MACE) and 30-day mortality. Of the 147 patients recruited, 13 (9%) died within 30 days and 33 (22%) had a MACE. Using univariate analysis, patients with severe AS had four times higher 30-day mortality than patients with moderate AS (16% versus 4%, P=0.007). Other factors associated with increased 30-day mortality included having a smaller aortic valve area, smaller dimensionless severity index, concomitant mitral regurgitation, and higher overall surgical risk. Patients with symptoms attributable to AS had a higher incidence of MACE compared to patients without symptoms (36% versus 16%, P=0.011). Variables significantly associated with both 30-day mortality and MACE were age, American Society of Anesthesiologists physical status, emergency surgery, New York Heart Association classification, preoperative albumin level, frailty, and history of congestive heart failure. Using multivariate analysis, emergency surgery, symptoms attributable to AS, preoperative albumin level, and AVA remained significantly associated with adverse outcome. While these findings should be interpreted with caution due to the observational nature of the study, limited power and multiple simultaneous comparisons, they suggest that patients with severe AS have a higher risk of adverse outcome after non-cardiac surgery than patients with moderate AS.
1
. The diagnosis of AS was based on clinical examination and AS was classified as 'important' or 'not important'. The study's multivariate analysis identified AS as a risk factor and assigned it three points. To place this score in context, multiple premature ventricular complexes were valued at seven points, age ≥70 years five points, and emergency surgery four points. Subsequent studies have been retrospective with conflicting results. Recent guidelines have been noncommittal stating "Elevated-risk elective non-cardiac surgery with appropriate intraoperative and postoperative hemodynamic monitoring is reasonable to perform in patients with asymptomatic severe aortic stenosis" 2 . Earlier guidelines quoted a mortality of ten percent associated with AS, but did not report on the similar mortality rate in the control group in the same study 3, 4 . The aim of this prospective multicentre observational study was to evaluate perioperative outcomes in this patient group and to identify preoperative factors associated with adverse outcome.
Methods
The study took place from August 2011 to September 2015 in five urban hospitals in New Zealand. The study was approved by the National Ethics Committee (Ref: MEC/10/073/EXP). Individual patient consent was not required as it was an observational study with no intervention.
In each hospital a local investigator coordinated data collection. Patients eligible for the study were identified by anaesthetists involved in their care and a password-protected database allowed patient information to be recorded by the local investigator or the anaesthetist. A meeting with all the local investigators took place prior to the study to standardise the trial design and data collection. Preoperative variables and outcome during and after surgery were recorded on the database until discharge. Echocardiography was undertaken by fully trained echocardiography technicians and reported by the participating hospital's cardiology service. If variables were not reported a local cardiologist was asked to review the recording and provide the missing data.
Preoperative variables recorded were age, sex, body mass index, American Society of Anesthesiologists (ASA) physical status, the revised cardiac risk index score (RCRI) 5 , history of ischaemic heart disease (IHD), history of congestive heart failure (CHF), cerebrovascular disease, insulin dependent diabetes mellitus (IDDM), renal impairment, atrial fibrillation, frailty, symptomatic status, current angina, syncope/presyncope, New York Heart Association (NYHA) functional classification, creatinine, glomerular filtration rate (GFR), albumin, cardiac biomarkers (N-terminal brain natriuretic peptide or brain natriuretic peptide), and a range of measurements from the echocardiogram (aortic valve area [ ). Patients with mild AS were excluded from the study as were patients who declined or were refused the planned surgery. If the mean gradient and/or peak velocity across the aortic valve was less than expected for the degree of stenosis measured by AVA, then the patient was defined as having 'low gradient AS'. Otherwise the term 'high gradient AS' was applied when the velocities and gradients matched that expected with the recorded AVA. Frailty was defined as reduced physical or mental function requiring assistance with aspects of daily living with patients classified as 'frail' or 'not frail'. Patients were classified as 'symptomatic' if their symptoms were attributed to AS rather than other coexisting comorbidities. Determining the contribution of comorbidities or AS to symptoms was at the discretion of the investigator. Moderate or severe comorbid disease was considered the cause of symptoms if present unless the symptoms were specific to AS (e.g. angina in a patient with obstructive pulmonary disease but no ischaemic heart disease). AS was considered the cause of symptoms in patients with mild comorbid disease and symptoms associated with AS.
The following outcomes were recorded: • Death within 30 days of surgery (30-day mortality).
• Major adverse cardiac events (MACE) not causing death during or after surgery up until hospital discharge. MACE were acute myocardial infarction, acute heart failure, arrhythmia with haemodynamic compromise and cardiac arrest with successful resuscitation. MACE and 30-day mortality data were collected by daily review of the patients during the admission. If the patients were discharged from hospital before the 30-day postoperative date, local hospital databases were checked for 'a date of death' record within 30 days of the operation. If no date of death was recorded, the database was checked for clinical contact after the 30-day deadline or the patients were contacted by phone. The associations between preoperative factors and the outcomes were assessed using Pearson's chi-square test or analysis of variance. A minimum sample size of 120 was required to detect an anticipated effect size (f 2 ) of 0.35 with a power of 0.9 and at a probability level of 0.05. Univariate differences with a P-value of 0.05 or less underwent multiple logistic regression analysis to identify independent variables associated with adverse outcome. The following dichotomous variables were included in the logistic regression:
• NYHA classification ≤2 and ≥3.
• GFR <30, 30 to 59 and ≥60 ml/minute.
• Albumin ≥30 or <30 g/litre.
• Cardiac biomarkers: elevated or non-elevated.
• LVEF: normal, ≥50% or reduced, <50%.
• LVPWT: normal or mild hypertrophy, ≤12 mm = normal; moderate and severe hypertrophy >12 mm = hypertrophy. • Diastolic function: normal/mild dysfunction = normal; moderate/severe dysfunction = diastolic dysfunction.
• MR: no MR/mild MR = no MR; moderate/severe MR = MR.
• AR: no AR/mild = no AR; moderate/severe = AR.
Results
A total of 147 patients were entered into the study. There were 64 females (43.5%) and 83 males (56.5%). Sixty-one (41.5%) had severe AS and 86 (58.5%) moderate AS. Most of the AS (142 cases, 96.6%) was degenerative in aetiology. Four cases (2.7%) were rheumatic and one (0.7%) congenital. Eighty-seven cases were classified as high gradient (59.1%) and 60 as low gradient (40.8%). Forty-one point five per cent of patients had orthopaedic surgery, 22.4% general surgery, 15.6% vascular surgery and 12.2% urological surgery. The remainder (8.3%) had dental, ear nose and throat, gynaecological, obstetric, ophthalmological, or plastic surgery. Most patients (104, 70.8%) had elective surgery. The preoperative patient variables for patients with severe and moderate AS are shown in Table 1 .
Fifty-six percent of patients were 80 years or older, 83% were classified as ASA ≥3, 39% were considered frail, 31% had a NYHA classification of ≥3, and 31% were symptomatic from their AS. Patients with severe AS had lower mean AVA and DSI values, were older, had higher ASA scores, were more often symptomatic, had a greater frequency of syncope and had more severe calcification of the valve. Patients with moderate AS had a higher incidence of IDDM and high-risk surgery than patients with severe AS. Twenty-nine (34%) patients with moderate AS and 31 (51%) with severe AS were classified as 'low gradient'.
Thirteen (9%) patients died within 30 days of surgery.
Thirty-three (22%) had a MACE. There were four (3%) in-hospital cardiac arrests; three occurred in theatre or a post-anaesthesia care unit (PACU). One was fatal in a patient with severe AS. Seventeen (12%) patients had an arrhythmia, nine (6%) myocardial infarction and 13 (9%) an episode of heart failure whilst in hospital. Nine (6%) patients had multiple adverse events. Fourteen (36%) of the MACE occurred in theatre or a PACU and 25 (64%) on the wards. Of the deaths within 30 days, ten (77%) occurred in hospital and three (23%) after discharge. Cardiac complications accounted for seven (54%) of these 13 deaths, of which six were in patients with severe AS. This accounted for 67% of deaths in the severe AS group at 30 days. One patient with moderate AS died due to a cardiac complication. Other causes of death were respiratory (two), gastrointestinal (two) and trauma (two). The univariate associations between preoperative factors and adverse outcomes are shown in Tables 2 and 3. In the univariate analysis, patients with severe AS were four times more likely to die within 30 days (P=0.007). There was no significant difference between high-and low-gradient groups across the outcomes. AVA, DSI, surgical risk and MR were significantly associated with 30-day mortality but not MACE. Analysis of symptomatic patients as a single group (severe and moderate combined) showed that they had a higher incidence of MACE compared to asymptomatic patients (36% versus 16%) but did not have a significant AS, aortic stenosis; ASA, American Society of Anesthesiologists physical status classification; IHD, ischaemic heart disease; CHF, history of congestive heart failure; CVD, cerebrovascular disease; IDDM, insulin dependent diabetes mellitus; RI, renal impairment; GFR, glomerular filtration rate; RCRI, revised cardiac risk index; AF, atrial fibrillation; NYHA, New York Heart Association functional classification; AVA, aortic valve area; DSI, dimensionless severity index; Ca + , calcification of aortic valve; LVEF, left ventricular ejection fraction; LVPWT, left ventricular posterior wall thickness; LVH, left ventricular hypertrophy; MR, mitral regurgitation; AR, aortic regurgitation; MACE, major adverse cardiac events; SD, standard deviation. increase in 30-day mortality (P=0.057). Variables significantly associated with both outcomes using univariate analysis were age, ASA physical status, emergency surgery, NYHA classification, albumin, frailty and a history of CHF.
All significant univariate variables underwent multifactorial logistic regression (Tables 4 and 5 
Discussion
The increasing incidence of AS in first world populations is largely related to advanced age, particularly in patients over the age of 75 years. As the size of the elderly population increases so too will the influence of AS on perioperative outcome. We found that severe AS is associated with higher 30-day mortality after non-cardiac surgery than moderate AS. The increased risk was related to valve area, with increasing valve area reducing risk (OR 0.03, CI 0 to 0.4). Patients undergoing emergency surgery and those with low albumin levels also had a higher incidence of MACE and 30-day mortality.
The first study considering AS in non-cardiac surgery was published in 1964. Fifty-nine patients with AS were reported, and had a 10% mortality rate 8 . In 1977, Goldman et al developed a perioperative risk index for non-cardiac surgery 1 . AS diagnosed clinically was included as a risk factor, with no echocardiography studies available. AS was defined as 'important AS' and relied on the presence of a systolic ejection murmur of at least grade two of six accompanied by carotid artery and cardiac examinations consistent with AS. Goldman calculated a 17% risk of a cardiac event in patients with AS, with a relative risk of a life-threatening complication of 3.2. Since 1977 other papers (Table 6 ) have been published on outcome in patients with AS undergoing non-cardiac surgery, but the Goldman paper remains the only other prospective study 4, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . The outcome parameters vary between studies and the reported influence of AS on outcome has been inconsistent. Amongst the most recent studies, Calleja et al compared asymptomatic severe AS with moderate AS and found no increased risk of death or MACE 17 .
In their study the only death was in the moderate stenosis group. Three large database studies had mixed results 18, 19, 20 . The findings by Anderson et al are difficult to interpret as the severity of AS could not be determined from the database and the definition of symptomatic was inferred from medications taken by the patients 19 . Agarwal et al identified symptomatic severe AS as an independent variable associated with outcome (OR 2.7) 18 . This was less than for high-risk surgery (OR 7.3) and MR (OR 9.8) and similar to that of IHD (OR 2.7). Asymptomatic AS was not associated with adverse outcome. Tashiro et al found no difference in mortality with severe AS but an increase in MACE 20 . This relationship was predominantly due to exacerbations of CHF.
Determining the contribution of AS to perioperative outcome is complicated by the multiple comorbidities found in elderly patients. Our study found a MACE rate of 22% and a 30-day mortality rate of 9%. However, 56% of the cohort were 80 years or older, 83% had an ASA physical status classification of ≥3 and 31% had a NYHA classification ≥3. A recent study of outcomes after elective surgery in 27 countries and 44,814 patients reported a perioperative mortality of 0.5%, which is clearly lower 21 . The Research into Elderly Patient Anaesthesia and Surgery Outcome Number (REASON) study had a more comparative elderly population, which is reflected in the higher 30-day mortality of 5% 22 . In our study, the mean AVA in patients who died was 0.8 cm 2 which, based on the OR from the multiple logistic regression analysis, would equate to an approximate doubling of mortality compared to patients with an AVA ≥2.0 cm 2 . Using the REASON study as a 'baseline', the expected mortality in our study would be about 10%, which is similar to the rate we observed. A recent retrospective study from Poland of three million patients undergoing non-cardiac surgery reported hospital mortality rates of 6% for 85-to 94-year-old patients and 13% for patients 95 years and over 23 . Relating our findings to other studies in patients with AS is confounded by varying cohorts and urgency of surgery. Calleja et al and Agarwal et al, who reported low rates of mortality and MACE did not include emergency surgery, and in the Agarwal study, 19% of patients underwent low-risk surgery 17, 18 . Tashiro et al included emergency surgery but this represented only 9% of cases 20 compared to 29% in our study. An overview of these studies suggests AS contributes to adverse outcome, but other factors such as advanced age and emergency surgery are also risk factors.
The most recent studies, although retrospective, have included control groups. Using a control group in patients with AS can be difficult as transthoracic echocardiography variables are usually unknown in the non-AS patients, yet may have a significant effect on outcome. Using patients with moderate AS as a control group and calculating the additional effect of severe AS is an alternative approach, which was used by Calleja et al 17 . In our study, we found a significant difference in adverse outcome between patients with severe and moderate AS using univariate, but not multivariate analyses. Despite the absence of a non-AS control group, the prospective nature of this study overcomes many of the problems associated with retrospective analysis of database information. Many previous studies generally had limited variables in their analysis and missed a number of potentially important factors such as albumin, ASA physical status classification and exercise tolerance. A strength of our study is that it recorded a wide range of perioperative variables that could potentially be associated with worse outcomes, many of which (e.g. age, ASA, surgical risk, CHF, NYHA classification, albumin) were significant on the univariate analysis. On the other hand, investigating a large number of variables increases the possibility of type I errors associated with multiple simultaneous comparisons.
Within the univariate analysis, frailty was associated with both adverse outcomes. We could not identify frailty as being an independent variable associated with outcome using multivariate analysis but the results suggest it is worth further study. Albumin remained independently associated with 30-day mortality and MACE on multivariate analysis. This would be expected and measurement of albumin concentration should be a routine preoperative test. Two studies have looked at the RCRI and its use in patients with AS 10, 20 . In our study RCRI was not significantly associated with adverse outcome. The role of cardiac biomarkers in this group of patients remains unclear. Unfortunately, there was inconsistent collection of this variable with a variety of tests performed using differing units of measurement. Small numbers and an incomplete dataset allowed only elevated Our classification of AS was based on AVA to avoid the confounding problem of low gradient states that could distort the groups if based on peak velocity or mean gradient. Within the sample, 41% of patients were classified as low gradient. This may seem at odds in a sample where only 26% of the patients had a potential cardiac explanation for the low gradient. The remainder of these patients probably represented patients in the normal flow/low gradient group, which is present in about 31% to 38% of patients with severe AS 24 . The study did not find an association between adverse outcome and low-gradient states or LVEF. This was consistent across patients with low gradients and within the groups of severe and moderate AS. The lack of flow measurements may explain why low gradient states were not associated with poor outcome as the normal flow/low gradient classification is a group of patients relatively early in the disease with a good prognosis. Measuring stroke volume would have enabled division into groups based on flow and gradient. This could not be achieved over all investigating sites. Future studies should endeavour to measure stroke volume allowing area, gradient and flow information to be integrated into the analysis. Excluding pseudo-severe AS would have improved the study, but stress echocardiography was not available. No other studies in non-cardiac surgery have addressed the potential for increased risk with low flow and/or low gradient AS. Studies on the natural history of AS and those undergoing aortic valve replacement suggest worse outcome in the low flow/low gradient patients and future studies should continue to include this aspect as a variable potentially associated with outcome 25, 26, 27 . Symptomatic patients had a worse outcome and this is consistent with results from other studies. During data collection it was made clear that symptoms should be related to the AS rather than other comorbidities. In many patients this was difficult to assess and a strength of the study was its prospective nature which allowed the investigators to decide on symptomatic status. A percentage of patients with moderate AS were classified as symptomatic. As the average AVA in the moderate AS group was 1.2 cm 2 , some of these patients were at least moderate-severe with others bordering on severe AS, which would explain these findings. Symptomatic status when divided into moderate and severe AS was not associated with adverse outcome, but as a single variable became significant using univariate analysis for both 30-day mortality and MACE. On multivariate analysis it remained a significant association with MACE. These findings suggest clinicians encountering moderate or severe AS should enquire about symptoms carefully, particularly in the moderate group where this aspect may be overlooked.
On univariate analysis severe AS, DSI and AVA were significantly associated with 30-day mortality, but not MACE. On multivariate analysis, only AVA as a continuous variable remained associated with 30-day mortality (OR 0.03 per each cm 2 , i.e. for every 1 cm 2 increase in AVA, risk reduced by 97%). This may change anaesthetic risk assessment from a binary model of moderate or severe AS to a more continuous risk profile, based on actual AVA. It suggests that even mild AS may have some association with adverse outcome. This would be consistent with recent studies identifying increased cardiovascular and all-cause mortality in patients with aortic sclerosis 28, 29 . These studies suggest the process of aortic valve thickening may be part of a wider pathology, with the changes at the valve reflecting a more widespread systemic inflammation (with lipid infiltration, tissue calcification and platelet dysfunction) which is an active rather than a degenerative process. This may fit better with a risk profile based on a continuing reduction in valve area rather than classification into discrete degrees of severity. In the future, other indices of the inflammatory process could be investigated which may be useful in defining the risk associated with reducing AVA.
Despite our multicentre approach and efforts to maximise recruitment, the study still suffers from small numbers. For example, to provide sufficient power for a multivariate model, at least ten adverse outcomes are required for each factor included. To limit the risk of creating over-specified models, only variables with significant values on univariate analysis were included in the multivariate models and only significant results in these models have been reported. Nevertheless, we had only 33 adverse outcomes, but included many more than three factors in our multivariate model. Moreover, our initial power analysis only allowed for the detection of relatively large differences, so small or medium effects may have been missed. The study also suffers from potential selection bias, as not all patients with AS in the hospitals participating were entered into the study. Despite these limitations, our study provides additional information on adverse outcome rates in patients with moderate or severe AS undergoing non-cardiac surgery, and identifies several factors that appear to be associated with adverse outcome.
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